Recombinant
RabMAb

Anti-MSH3 antibody [EPR4334(2)] (ab111107)

Publishing research using ab111107? Please let us know so that we can cite the reference in this datasheet.

ab111107 has been referenced in 1 publication.

  • Ni H  et al. Inactivation of MSH3 by promoter methylation correlates with primary tumor stage in nasopharyngeal carcinoma. Int J Mol Med 40:673-678 (2017). PubMed: 28656302

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up